N-Glycolylneuraminic acid in human tumours

Biochimie

Volumn 83, Issue 7, 2001, Pages 623-634

  Malykh, Y N ^a   Schauer, R ^a   Shaw, L ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cancer; CMP Neu5Ac hydroxylase; Hanganutziu Deicher; Sialic acid; Tumour associated antigen

Indexed keywords

GLYCOCONJUGATE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; OXYGENASE; SIALIC ACID; TUMOR MARKER;

AMINO ACID SYNTHESIS; ANALYTIC METHOD; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; BREAST CANCER; CANCER; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER TISSUE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE DELETION; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MELANOMA; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

ANIMALIA; HOMO SAPIENS;

EID: 0034844959     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01303-7     Document Type: Article

References (109)

1. Diversity in the sialic acids
2. Chemistry, biochemistry and biology of sialic acids
3. The distribution sialic acids in nature
4. Occurrence of sialic acids
5. A structural difference between the cell surfaces of humans and the great apes
6. Biosynthesis and biology of N-glycolylneuraminic acid
7. Sialic acids in molecular and cellular interactions
8. Biochemistry and oncology of sialoglycoproteins
9. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
10. Protein glycosylation in cancer biology: An overview
11. Perspectives on the significance of altered glycosylation of glycoproteins in cancer
12. Hémagglutinines hétérogénétiques après injection de sérum de cheval
13. Über die Erzeugung heterospezifischer Hämagglutinine durch Injektion artfremden Serums
14. Antigen of 'serum sickness' type of heterophile antibodies in human sera: Indentification as gangliosides with N-glycolylneuraminic acid
15. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolyl-neuraminic acid
16. Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues
17. N-glycolylneuraminic acid-containing glycoconjugates as tumor-associated antigen
18. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid
19. Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry
20. MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of O-glycosylation
21. Gangliosides expressed in human breast cancer
22. The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid
23. Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver
24. Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool
25. A study on the regulation of N-glycoloylneuraminic acid biosynthesis and utilization in rat and mouse liver
26. 5 purified from horse erythrocytes
27. 5-dependent electron transport chains
28. CMP-N-acetylneuraminic acid hydroxylase: The first cytosolic Rieske iron-sulphur protein to be described in Eukarya
29. The role of CMP-N-acetylneuraminic acid hydroxylase in determining the level of N-glycolylneuraminic acid in porcine tissues
30. Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species- and tissue-specific expression of N-glycolylneuraminic acid
31. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo- Pan divergence
32. The molecular basis for the absence of N-glycolylneuraminic acid in humans
33. CMP-N-acetylneuraminic acid hydroxylase is exclusively inactive in humans
34. Diversity at the 5-carbon position of sialic acids
35. Horizontal circular chromatography of sialic acids from serum of certain mammal species
36. Importance of high-performance liquid chromatographic analysis of serum N-acylneuraminic acids in evaluating surgical treatment in patients with early endometrial cancer
37. Improved methods for the isolation and structural analysis of trace amounts of new sialic acids - Identification of N-glycolylneuraminic acid in man, Glycoconjugates
38. Expression of Hanganutziu-Deicher antigen in activated human T lymphocytes
39. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers
40. Expression of N-glycolyl-neuraminic acid in normal, fetal and malignant human tissues
41. Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence
42. Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers
43. Detection of glycoproteins as tumor-associated Hanganutziu-Deicher antigen in human gastric cancer cell line, NUGC4
44. Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma
45. Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies
46. Specificities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingolipids
47. Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells
48. Detection of Hanganutziu-Deicher antigen in patients with hepatocellular carcinoma
49. Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma
50. Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum
51. Sensitive enzyme-immunostaining and densitometric determination on thin-layer chromatography of N-glycolylneuraminic acid-containing glycosphingo-lipids, Hanganutziu-Deicher antigen
52. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer
53. Detection of 4-O-acetyl-N-glycolylneuraminyl lactosylceramide as one of tumor-associated antigens in human colon cancer tissues by specific antibody
54. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas
55. N-glycolylneuraminic acid-containing gangliosides in human melanoma and related antibodies in patients bearing melanoma tumors
56. Heterophile Hanganutziu-Deicher antigen in ganglioside fractions of human melanoma tissues
57. Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells
58. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies
59. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides
60. Characterization of ganglioside expression in human melanoma cells: Immunological and biochemical analysis
61. Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids
62. A human monoclonal antibody derived from axillary lymph nodes of a breast cancer patient reactive to a sulfated glycolipid
63. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors
64. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides
65. Immunohistochemical detection of heterophile Hanganutziu-Deicher antigen in human malignant melanoma
66. A new breast carcinoma antigen defined by a monoclonal antibody
67. Expression of MUC1 and MUC2 mucins by human tumor cell lines
68. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2
69. Two-dimensional mapping by the high-performance liquid chromatography of oligosaccharides released from glycosphingolipids by endoglycoceramidase
70. N-glycolylneuraminic acid is a chemical marker of gangliosides from human breast carcinoma
71. Potential use of specific human and chicken antibodies for detection of Hanganutziu-Deicher antigen(s) in sera of cancer patients
72. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2
73. Heterophile antibodies in pathologic human sera resembling antibodies stimulated by foreign species sera
74. Hanganutziu-Deicher antibodies in infectious mononucleosis and other diseases
75. A specific enzyme-linked immunosorbent assay (ELISA) procedure for detection of heterophile Hanganutziu and Deicher (HD) antibodies
76. Studies on Hanganutziu-Deicher antigens-antibodies. I. Hanganutziu-Deicher antibodies of IgG class in liver diseases
77. Survey of Hanganutziu and Deicher antibodies in operated patients
78. A potential radioimmunoassay system for detection of Hanganutziu-Deicher type heterophile antigen(s) and antibodies in tissues and fluids
79. Expression of heterophile, Paul-Bunnell and Hanganutziu-Deicher antigens on human melanoma cell lines
80. Réponse de malades atteints de mélanome á l'immunisation par oncolisats de mélanome au virus de la vaccine
81. Specificities of human heterophile Hanganutziu and Deicher (HD) antibodies to glycosphingolipids and a glycoprotein
82. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barre syndrome
83. Sialic acids in fungi: A minireview
84. Bovine albumin-like protein in commercial human albumin for clinical use
85. The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancer
86. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer
87. Application of mammary serum antigen assay in the management of breast cancer: A preliminary report
88. Evaluation of MSA as a serum marker in breast cancer: A comparison with CEA
89. Mammary serum antigen (MSA) in advanced breast cancer
90. Mammary serum antigen (MSA) levels as a marker for breast cancer: A survey of blood donors and patients with cancer
91. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: A prospective study
92. Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides
93. Delineation of the epitope recognized by an antibody specific for N-glycolylneuraminic acid-containing gangliosides
94. Immune responses in melanoma patients immunized with an anti-idiotype (ID) antibody mimicking N-glycolyl containing gangliosides
95. Phase I clinical trial of the ganglioside conjugated cancer vaccine N-glycolyl-GM3/VSSP/Montanide ISA 51
96. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation
97. The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin
98. Efficient uptake of free sialic acids in eukaryotic cells
99. Uptake, metabolism and excretion of orally and intravenously administered, double-labeled N-glycoloylneuraminic acid and single-labeled 2-deoxy-2,3-dehydro-N-acetylneuraminic acid in mouse and rat
100. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: Inhibition of myelin-associated glycoprotein binding to neuronal cells
101. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process
102. Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice
103. Subcellular distribution of glycolyltransferases in rodent liver and their significance in special reference to the synthesis of N-glycolyneuraminic acid
104. Studies on the metabolism of glycolyl-CoA
105. Metabolism of sialic acids
106. Biosynthesis and turnover of O-acetyl and N-acetyl groups in the gangliosides of human melanoma cells
107. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides
108. Two chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigens
109. Detection of N-glycolylneuraminic acid-containing glycoproteins from various animal erythrocytes by chicken monoclonal antibody against Hanganutziu-Deicher antigens